The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
- Author
- Bert Vander Cruyssen (UGent) , Clio Ribbens, Annelies Boonen, Herman Mielants (UGent) , Kurt De Vlam (UGent) , Jan Lenaerts, Serge Steinfeld, Filip Van den Bosch (UGent) , Lode Dewulf and Nathan Vastesaeger
- Organization
- Keywords
- PLACEBO-CONTROLLED TRIAL, ASAS CONSENSUS STATEMENT, DOUBLE-BLIND, DISEASE-ACTIVITY, AGENTS, INDEX, BATH, SPONDYLARTHROPATHY, MULTICENTER, INFLIXIMAB
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 214.40 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-388415
- MLA
- Vander Cruyssen, Bert, et al. “The Epidemiology of Ankylosing Spondylitis and the Commencement of Anti-TNF Therapy in Daily Rheumatology Practice.” ANNALS OF THE RHEUMATIC DISEASES, vol. 66, no. 8, 2007, pp. 1072–77, doi:10.1136/ard.2006.064543.
- APA
- Vander Cruyssen, B., Ribbens, C., Boonen, A., Mielants, H., De Vlam, K., Lenaerts, J., … Vastesaeger, N. (2007). The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. ANNALS OF THE RHEUMATIC DISEASES, 66(8), 1072–1077. https://doi.org/10.1136/ard.2006.064543
- Chicago author-date
- Vander Cruyssen, Bert, Clio Ribbens, Annelies Boonen, Herman Mielants, Kurt De Vlam, Jan Lenaerts, Serge Steinfeld, Filip Van den Bosch, Lode Dewulf, and Nathan Vastesaeger. 2007. “The Epidemiology of Ankylosing Spondylitis and the Commencement of Anti-TNF Therapy in Daily Rheumatology Practice.” ANNALS OF THE RHEUMATIC DISEASES 66 (8): 1072–77. https://doi.org/10.1136/ard.2006.064543.
- Chicago author-date (all authors)
- Vander Cruyssen, Bert, Clio Ribbens, Annelies Boonen, Herman Mielants, Kurt De Vlam, Jan Lenaerts, Serge Steinfeld, Filip Van den Bosch, Lode Dewulf, and Nathan Vastesaeger. 2007. “The Epidemiology of Ankylosing Spondylitis and the Commencement of Anti-TNF Therapy in Daily Rheumatology Practice.” ANNALS OF THE RHEUMATIC DISEASES 66 (8): 1072–1077. doi:10.1136/ard.2006.064543.
- Vancouver
- 1.Vander Cruyssen B, Ribbens C, Boonen A, Mielants H, De Vlam K, Lenaerts J, et al. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. ANNALS OF THE RHEUMATIC DISEASES. 2007;66(8):1072–7.
- IEEE
- [1]B. Vander Cruyssen et al., “The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice,” ANNALS OF THE RHEUMATIC DISEASES, vol. 66, no. 8, pp. 1072–1077, 2007.
@article{388415, author = {{Vander Cruyssen, Bert and Ribbens, Clio and Boonen, Annelies and Mielants, Herman and De Vlam, Kurt and Lenaerts, Jan and Steinfeld, Serge and Van den Bosch, Filip and Dewulf, Lode and Vastesaeger, Nathan}}, issn = {{0003-4967}}, journal = {{ANNALS OF THE RHEUMATIC DISEASES}}, keywords = {{PLACEBO-CONTROLLED TRIAL,ASAS CONSENSUS STATEMENT,DOUBLE-BLIND,DISEASE-ACTIVITY,AGENTS,INDEX,BATH,SPONDYLARTHROPATHY,MULTICENTER,INFLIXIMAB}}, language = {{eng}}, number = {{8}}, pages = {{1072--1077}}, title = {{The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice}}, url = {{http://doi.org/10.1136/ard.2006.064543}}, volume = {{66}}, year = {{2007}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: